Indian antimicrobial prescription guidelines in critically ill immunocompromised patients

Atul P. Kulkarni, Manju Sengar, Girish Chinnaswamy, Ashit Hegde, Camilla Rodrigues, Rajeev Soman, Gopi C. Khilnani, Suresh Ramasubban, Mukesh Desai, Rahul Pandit, Ruchira Khasne, Anjali Shetty, Trupti Gilada, Shilpushp Bhosale, Amol Kothekar, Subhal Dixit, Kapil Zirpe, Yatin Mehta, Jacob George Pulinilkunnathil, Vikas BhagatMohammad Saif Khan, Amit M. Narkhede, Nishanth Baliga, Srilekha Ammapalli, Shrirang Bamne, Siddharth Turkar, K. Vasudeva Bhat, Jitendra Choudhary, Rishi Kumar, Jigeeshu V. Divatia

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

INTRODUCTION The number of admissions of immunocompromised patients in the Indian intensive care units (ICUs) is growing. This is because of availability of better treat­ments for acquired immunodeficiency states, increasing incidence and detection of cancer, with more aggressive therapies aimed at cancer cure, and increased expecta­tions of better ICU outcomes in the cancer patient1,2.

Original languageEnglish
Pages (from-to)64-96
Number of pages33
JournalIndian Journal of Critical Care Medicine
Volume23
DOIs
Publication statusPublished - 2019

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'Indian antimicrobial prescription guidelines in critically ill immunocompromised patients'. Together they form a unique fingerprint.

Cite this